Skip to main content
Premium Trial:

Request an Annual Quote

GATC Buys Second 454 GS FLX System

NEW YORK (GenomeWeb News) – GATC Biotech has purchased a second Genome Sequencer FLX system from Roche’s 454 Life Sciences’ subsidiary, 454 announced today.
 
“Having two Genome Sequencer FLX Systems available enables us to execute very demanding sequencing projects on short notice and handle production peaks much better," Thomas Pohl, CTO of GATC, said in a statement. “For example, we are able to run one instrument with a paired-end application and the other one with single reads.”
 
Germany’s GATC, which provides sequencing services, purchased its first GS FLX system in March 2007.
 
Last summer, it also purchased and began offering sequencing services using Applied Biosystems’ SOLiD sequencer.
 

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.